Anxiety · GAD-7

How anxious are you really?

A escala GAD-7 (Perturbação de Ansiedade Generalizada, 7 itens) é o instrumento validado mais amplamente utilizado para detetar e medir a gravidade da ansiedade. Desenvolvida na Universidade de Columbia, é reconhecida por clínicos em todo o mundo.

⏱ 3 min ❓ 7 perguntas ✓ 100% Free
▶ Iniciar Teste Gratuito
🔒 No registration · Instant results
🔬 Rastreio de Ansiedade (GAD-7)
▶ Iniciar Teste Agora
Download sample PDF →
⚠️ Aviso: Esta ferramenta é apenas informativa e não constitui um diagnóstico médico. Se a ansiedade afeta a sua vida diária, consulte um profissional de saúde.
Claude AI
Interpretação de IA por Claude (Anthropic)
claude-sonnet-4-20250514
Your results are analyzed by Claude, Anthropic's AI model, which provides a personalized narrative explaining what your answers reveal about your profile, with practical recommendations and professional guidance.

📋 What to expect

Responda honestamente Não há respostas certas ou erradas
Tome seu tempo Leia cada pergunta com cuidado antes de responder
Interpretação de IA A IA Claude vai analisar e explicar seus resultados
PDF Report Get a full PDF report of your results

What is Generalised Anxiety Disorder?

Generalised Anxiety Disorder (GAD) is characterised by excessive, persistent worry about various areas of daily life (work, health, family, finances), difficult to control and present on most days for at least 6 months. GAD affects approximately 6% of people at some point in their lives. It differs from ordinary stress by its pervasive nature, persistence, and accompanying physical symptoms (muscle tension, sleep disturbance, fatigue).

Common symptoms

GAD symptoms include: excessive and difficult-to-control worry, irritability, concentration difficulties, chronic fatigue, muscle tension, sleep disturbances, and a constant feeling of being on edge. Work-related anxiety, night-time rumination, and avoidance of stressful situations are also characteristic.

About the GAD-7

The GAD-7 is a validated anxiety screening and severity scale developed by Spitzer et al. (2006), published in Archives of Internal Medicine. It is widely used in primary care and clinical research. A score ≥ 10 is associated with moderate-to-severe GAD warranting clinical evaluation.